Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03575793
Title A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jyoti Malhotra
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Erlanger Health System Chattanooga Tennessee 37403 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field